Psychiatry & Neurology Doctors in Aberdeen, NJ Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Ms. Sahar Fathi Awad, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1130 Hwy 34, Aberdeen, NJ 07747 Phone: 732-970-6100

Mr. Maher Awad, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1130 Highway 34, Aberdeen, NJ 07747 Phone: 732-591-9100    Fax: 732-219-0814

Robert J Bennett, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1088 State Route 34, Aberdeen, NJ 07747 Phone: 732-290-1700    Fax: 732-290-0040

News Archive

Dicerna Pharmaceuticals and Kyowa Hakko Kirin sign research collaboration and license agreement

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.

Medicare expenditures, quality rating system grab headlines

Kaiser Health News looks at criticisms of the government's program for rewarding higher-quality Medicare Advantage plans, while Modern Healthcare reports on a memo from the Medicare actuary that projects expenditures in the federal healthcare program.

Health law implementation: Insurance, coverage and Medicare payment questions

Kaiser Health News reports that the insurance industry — traditionally a state-regulated industry — is facing new federal scrutiny by four officials in the new Office of Consumer Information and Insurance Oversight. "On this year's to-do list: writing rules to define when premium increases are 'unreasonable,' creating new coverage for people who can't get it because of health conditions and making sure insurers comply with consumer protections. The new director of the office is Jay Angoff, a former Missouri insurance commissioner.

Endologix receives IDE conditional approval from FDA

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair (EVAR) utilizing the Company's IntuiTrak(TM) endovascular delivery system for the Powerlink® family of stent grafts.

New study sheds light on possible role of ion channel in the immune system

Many cells have microscopic gates, called ion channels, which open to allow the flow of ions across the cell membrane. Thanks to these gates, cells can detect stimuli such as heat, pain, pressure and even spicy food.

Read more Medical News

› Verified 2 days ago